Leaders of ten US medical associations took $130 million from industry in three years; psychiatry's median was $212

A BMJ study matched 328 leaders of ten US medical associations to Open Payments. 72 percent had a financial tie, median $31,805. The American Psychiatric Association's leaders had a median of $212; oncology's, $518,000.

not yet assessed

We have not finished checking this source. No judgement either way. how we score evidence

Caveat on this rating: Open Payments records manufacturer-reported payments to physicians only; leaders who are not physicians are invisible to it. Funding for the study is not stated in the record we read. A payment is not evidence of influence and the study does not claim one.

Significant findings

Moynihan and colleagues took the leaders of the ten US professional medical associations covering the costliest disease areas, 328 people, and looked each one up in Open Payments, the federal database of what drug and device manufacturers pay physicians, for 2017 to 2019.

235 of 328 leaders, 72 percent, had an industry financial relationship; among the 293 who were medical doctors or doctors of osteopathy, 80 percent did. Total payments were about $130 million: $24.8 million in general payments and $104.6 million in research payments. The median per leader was $31,805.

The variation between associations was the finding. The American Society of Clinical Oncology's leaders had a median of $518,000; the American College of Rheumatology's $251,464; the American College of Physicians' $404; the American Psychiatric Association's $212.

The authors' conclusion, verbatim: "Financial relationships between the leaders of influential US professional medical associations and industry are extensive, although with variation among the associations."

Worth asking

On the government's own records, psychiatry's association leadership sat at the bottom of that variation. The same database tells a different story about the profession's rank and file, which is the next row. Both are true at once.

Source

Financial ties between leaders of influential US professional medical associations and industry: cross sectional study — Moynihan R, Albarqouni L, Nangla C, Dunn AG, Lexchin J, Bero L (2020)

Read the source: https://doi.org/10.1136/bmj.m1505

DOI: 10.1136/bmj.m1505

How this was scored

Study design
not recorded
Funding
not recorded
Published in
not recorded
Sample size
328
Preregistered
not recorded
Conflicts disclosed
not recorded
Independent of proponent
not recorded
Retracted
No

We have not finished checking this source, so there is no scoring to show yet. “We have not checked this yet” and “this is disputed” are different statements, so no scored band is shown rather than a low one.

Read the full scoring rubric, including what it can't tell you.

Published September 21, 2026.

Questions

How strong is the evidence behind this?

veisund rates this source "not yet assessed". We have not finished checking this source. No judgement either way. One caveat travels with that badge: Open Payments records manufacturer-reported payments to physicians only; leaders who are not physicians are invisible to it. Funding for the study is not stated in the record we read. A payment is not evidence of influence and the study does not claim one. The score is calculated from recorded facts about the source — study design, funding, publication venue, sample size, preregistration — not typed in by an editor.

What is the source for this?

Financial ties between leaders of influential US professional medical associations and industry: cross sectional study — Moynihan R, Albarqouni L, Nangla C, Dunn AG, Lexchin J, Bero L (2020). DOI: 10.1136/bmj.m1505. The full source is linked on this page so you can read it yourself.

Is this medical advice?

This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.

This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.